MRSN•benzinga•
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
Summary
Mersana shares Phase 1 data on Emi-Le for TNBC and details FDA's Fast Track status for XMT-1660 in advanced HER2-low breast cancer.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga